Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG 14/001 BR.31

A phase III prospective double blind placebo controlled randomized study of adjuvant MEDI4736 in completely resected non-small cell lung cancer.

This multicentre, international trial is being coordinated by the NCIC Clinical Trials Group in collaboration with ALTG and NHMRC Clinical Trials Centre. The study has recently opened to recruitment in Australia, with a plan to recruit 200 patients across 25 Australian and 1 New Zealand site over a 3 year period. This study is looking at the impact of adjuvant therapy with MEDI4736 given by intravenous infusion for one year on the disease free survival and overall survival of patients with early stage (IB >4cm, II or IIIA) NSCLC.

Active/planned sites:

Site Name

Principal Investigator

Activation date

Austin Hospital

Shane White


Campbelltown Hospital

Po Yee Yip


Canberra Hospital

David Leong


Canterbury Regional Cancer and Haematology Service

David Gibbs


Central Coast Cancer Centre

Matthew Chan


Chris O'Brien Lifehouse

Steven Kao


Coffs Harbour Health Campus - NCCI

Karen Briscoe

July 2015

Epworth Richmond Hospital

Ross Jennens


Fiona Stanley Hospital

Andrew Davidson


Flinders Medical Centre

Anand Rose


Liverpool Hospital

Victoria Bray


Mater Adult Hospital Brisbane

Felicity Murphy


Monash Medical Centre

Peter Briggs


Nambour General Hospital

Kathleen Houston
Jeremy Long


Nepean Cancer Care Centre

Catherine Crombie


Northern Cancer Institute St Leonards

Nick Pavlakis


Peninsula Oncology Centre, Frankston, Victoria

Vinod Ganju


Prince Charles Hospital

Brett Hughes

July 2015

Princess Alexandra Hospital

Ken O'Byrne


Royal Adelaide Hospital

Michael Brown

July 2015

Royal Hobart Hospital

Louise Nott


Royal Melbourne Hospital, Parkville, Victoria, Australia

Richard de Boer

Aug 2015

Sir Charles Gairdner Hospital

Michael Millward


St George Hospital

Chee Lee


St Vincent's Hospital Melbourne including St Vincent's Private Hospital

Sue-Anne McLachlan
ANZ Study Chair

July 2015

Westmead Hospital

Rina Hui



Study Chair: Sue-Anne McLachlan

Email: sue-anne.mclachlan@svhm.org.au

CTC Trial Coordinator: Hannora Jurkovic

Email: BR.31@ctc.usyd.edu.au